These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 33931360)

  • 1. Effectiveness of supplemental oral calcium drink in preventing citrate-related adverse effects in peripheral blood progenitor cell collection.
    Fujii K; Fujii N; Kondo T; Mitsuhashi T; Nakamura M; Seike K; Sando Y; Kimura M; Matsuda M; Ikegawa S; Sugiura H; Otsuka F; Maeda Y
    Transfus Apher Sci; 2021 Aug; 60(4):103147. PubMed ID: 33931360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment for the decline of ionized calcium levels during peripheral blood progenitor cell harvesting.
    Kishimoto M; Ohto H; Shikama Y; Kikuta A; Kimijima I; Takenoshita S
    Transfusion; 2002 Oct; 42(10):1340-7. PubMed ID: 12423519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prophylactic low dose continuous calcium infusion during peripheral blood stem cell (PBSC) collections to reduce citrate related toxicity.
    Hegde V; Setia R; Soni S; Handoo A; Sharma SK; Chaudhary D; Kapoor M
    Transfus Apher Sci; 2016 Jun; 54(3):373-6. PubMed ID: 26915952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Collection of hematopoietic progenitor cells from healthy donors].
    Bojanić I; Cepulić BG; Mazić S
    Acta Med Croatica; 2009 Jun; 63(3):237-44. PubMed ID: 19827352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction of adverse citrate reactions during autologous large-volume PBPC apheresis by continuous infusion of calcium-gluconate.
    Buchta C; Macher M; Bieglmayer C; Höcker P; Dettke M
    Transfusion; 2003 Nov; 43(11):1615-21. PubMed ID: 14617323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcium supplementation attenuates citrate-related changes in bone metabolism: a placebo-controlled crossover study in healthy volunteers.
    Chen Y; Hou J; Chen G; Lin H; Lin H; Chu X; Zeng J; Chen C; Lin J; Dettke M
    Bone; 2011 Sep; 49(3):506-12. PubMed ID: 21635981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controlled study of citrate effects and response to i.v. calcium administration during allogeneic peripheral blood progenitor cell donation.
    Bolan CD; Cecco SA; Wesley RA; Horne M; Yau YY; Remaley AT; Childs RW; Barrett AJ; Rehak NN; Leitman SF
    Transfusion; 2002 Jul; 42(7):935-46. PubMed ID: 12375668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive technical and patient-care optimization in the management of pediatric apheresis for peripheral blood stem cell harvesting.
    Ohara Y; Ohto H; Tasaki T; Sano H; Mochizuki K; Akaihata M; Kobayashi S; Waragai T; Ito M; Hosoya M; Nollet KE; Ikeda K; Ogawa C; Kanno T; Shikama Y; Kikuta A
    Transfus Apher Sci; 2016 Dec; 55(3):338-343. PubMed ID: 27765663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased risk of citrate reactions in patients with multiple myeloma during peripheral blood stem cell leukapheresis.
    Adamski J; Griffin AC; Eisenmann C; Milone MC; Sachais BS
    J Clin Apher; 2010; 25(4):188-94. PubMed ID: 20818713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-versus standard-dose filgrastim (rhG-CSF) for mobilization of peripheral-blood progenitor cells from allogeneic donors and CD34(+) immunoselection.
    Engelhardt M; Bertz H; Afting M; Waller CF; Finke J
    J Clin Oncol; 1999 Jul; 17(7):2160-72. PubMed ID: 10561272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A liquid calcium+vitamin D
    Weinstein R; Haynes S; Zhao Y; Hickson E; Linden J; St Pierre P; Ducharme P; Sulmasy P; Graves M; Bailey JA; Welch L; Simard A; Vauthrin M; Greene M
    J Clin Apher; 2018 Feb; 33(1):60-64. PubMed ID: 28653765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allogeneic blood progenitor cell collection in normal donors after mobilization with filgrastim: the M.D. Anderson Cancer Center experience.
    Anderlini P; Donato M; Chan KW; Huh YO; Gee AP; Lauppe MJ; Champlin RE; Körbling M
    Transfusion; 1999 Jun; 39(6):555-60. PubMed ID: 10378833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticoagulation techniques in apheresis: from heparin to citrate and beyond.
    Lee G; Arepally GM
    J Clin Apher; 2012; 27(3):117-25. PubMed ID: 22532037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prophylactic infusion of calcium gluconate to prevent a symptomatic fall in plasma ionized calcium during therapeutic plasma exchange: A comparison of two methods.
    Zhao Y; Linden J; Welch L; St Pierre P; Graves M; Garrity D; Ducharme P; Bailey JA; Greene M; Vauthrin M; Weinstein R
    J Clin Apher; 2018 Oct; 33(5):600-603. PubMed ID: 30098216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium supplement increase on the second day of sequential two day leukapheresis.
    Asai T; Shimizu N; Narita M; Kobayashi M
    Ther Apher; 2001 Dec; 5(6):466-70. PubMed ID: 11800082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mobilization of hematopoietic progenitor cells from allogeneic healthy donors using a new biosimilar G-CSF (Zarzio®).
    Antelo ML; Zabalza A; Sánchez Antón MP; Zalba S; Aznar M; Mansilla C; Ramírez N; Olavarría E
    J Clin Apher; 2016 Feb; 31(1):48-52. PubMed ID: 26011178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Collection of Peripheral Blood Progenitor Cells in 1 Day Is Associated with Decreased Donor Toxicity Compared to 2 Days in Unrelated Donors.
    Hsu JW; Shaw BE; Kim S; Logan BR; Sees JA; Confer DL; Pulsipher MA; Shah N; Switzer GE; Abidi MH; Ahmed IA; Anderlini PN; Bredeson C; Chhabra S; Dandoy CE; Diaz MA; Farhadfar N; Ganguly S; Gergis U; Hale GA; Hematti P; Kamble RT; Kasow KA; Lazarus HM; Liesveld JL; Murthy HS; Olsson RF; Savani BN; Schears R; Seo S; Solh M; Spitzer T; Steinberg A; Sugrue M; Warkentin P; Wingard JR
    Biol Blood Marrow Transplant; 2020 Jun; 26(6):1210-1217. PubMed ID: 32088366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic plasma exchange performed in tandem with hemodialysis without supplemental calcium in the apheresis circuit.
    Zhao Y; Ibrahim H; Bailey JA; Linden J; Hickson E; Haynes S; Greene M; Vauthrin M; Weinstein R
    J Clin Apher; 2017 Jun; 32(3):154-157. PubMed ID: 27172986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feasibility and cost analysis of day 4 granulocyte colony-stimulating factor mobilized peripheral blood progenitor cell collection from HLA-matched sibling donors.
    Newell LF; Shoop KM; Knight RJ; Murray SN; Kwock RP; Jacoby CE; Slater S; Allen BE; Ottowa C; Cota B; Appel PL; Cook RJ; Maziarz RT; Meyers G
    Cytotherapy; 2019 Jul; 21(7):725-737. PubMed ID: 31085121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Collection of peripheral blood progenitor cells on Day 4 is feasible and effective while reducing granulocyte-colony-stimulating factor exposure to healthy donors.
    Flommersfeld S; Sohlbach K; Jaques G; Bein G; Hoffmann J; Kostrewa P; Sachs UJ
    Transfusion; 2015 Jun; 55(6):1269-74. PubMed ID: 25647638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.